Dose-Response Relationships

In pharmacodynamics, a dose-response relationship describes how the magnitude of a drug's effect changes as a function of the dose administered or the concentration achieved at the site of action. Quantifying this relationship - most often as a sigmoid curve on a logarithmic dose axis - is the core empirical foundation for comparing drugs by potency and efficacy and for understanding how receptor occupancy is translated into a biological response.

Definition

A dose-response relationship is the quantitative association between the dose or concentration of a drug and the magnitude of the resulting pharmacological effect, characterised graphically by a dose-response (concentration-effect) curve and summarised numerically by parameters such as the half-maximal effective concentration and the maximal effect.

Scope

This area orients the reader to the graded and quantal forms of the dose-response relationship and to the parameters derived from them: potency and efficacy, the half-maximal points ED50, EC50 and IC50, the quantal LD50 and therapeutic index, and the Hill equation that gives the curve its shape. It frames these as quantitative pharmacology concepts; it is reference-educational and contains no dosing or treatment guidance.

Core questions

• How is the magnitude of a drug effect related to the dose or concentration?
• What distinguishes a graded dose-response curve from a quantal one?
• Which parameters - potency, efficacy, EC50, Emax - summarise a dose-response curve, and what does each mean?
• How does the Hill equation describe the typically sigmoid shape of the curve?

Key concepts

• Graded dose-response curve
• Quantal dose-response curve
• Sigmoid concentration-effect relationship
• Potency and efficacy
• EC50, ED50, and IC50
• Maximal effect (Emax)
• Therapeutic index and LD50
• Hill equation and Hill coefficient

Mechanisms

A drug produces an effect by interacting with a molecular target, and as dose or concentration rises the effect increases until a maximum (Emax) is reached, where the target is fully engaged or a downstream step becomes limiting. Plotting effect against the logarithm of dose typically yields a sigmoid curve whose position on the dose axis reflects potency and whose height reflects efficacy. The graded form describes how the size of a continuous response varies in a single system, while the quantal form describes the cumulative fraction of a population that reaches a defined all-or-none endpoint as dose increases. The Hill equation provides the standard mathematical description of the sigmoid, with the half-maximal point (EC50/ED50) and the Hill coefficient as its defining parameters. Standardised terminology for these quantities is set out by the IUPHAR committee on quantitative pharmacology.

Clinical relevance

Dose-response analysis underlies how the relative potency, maximal effect and safety margin of drugs are compared and communicated in the health sciences. This area presents the concepts at the level of quantitative pharmacology for reference; it describes how drug effects are characterised and is not a basis for individual prescribing or dose selection.

Evidence & guidelines

Standardised terms and symbols for dose-response parameters are maintained by the IUPHAR committee on receptor nomenclature and quantitative pharmacology, and the underlying theory is consolidated in standard pharmacology textbooks.

History

Quantitative dose-response analysis grew out of early twentieth-century work linking drug concentration to receptor occupancy and biological effect. A. V. Hill's modelling of binding cooperativity (1910) supplied the equation later adopted for sigmoid concentration-effect curves, Trevan introduced the LD50 as a way to quantify toxicity (1927), and Black and Leff's operational model (1983) formalised how agonist concentration maps to tissue response. Colquhoun's history traces how these strands consolidated into the quantitative pharmacology now codified in IUPHAR terminology.

Key figures

• Archibald Vivian Hill
• John William Trevan
• James Whyte Black
• Terry Kenakin
• David Colquhoun

Seminal works

• neubig-2003
• colquhoun-2006
• goutelle-2008

Frequently asked questions

Why are dose-response curves usually plotted against the logarithm of dose?

Drug effects often span several orders of magnitude of concentration; a logarithmic dose axis spreads these out and turns the underlying relationship into an approximately symmetric sigmoid, making the half-maximal point and the linear mid-range easy to read and compare.

What is the difference between a graded and a quantal dose-response curve?

A graded curve plots the continuously varying magnitude of a response in an individual system against dose; a quantal curve plots the cumulative proportion of a population reaching an all-or-none endpoint against dose, and is used to derive population parameters such as ED50 and LD50.